HOME > ARCHIVE
ARCHIVE
- The 63rd Meeting of the Japanese Cancer Association
October 18, 2004
- BULLETIN
October 18, 2004
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
October 18, 2004
- EPMA Member Companies Report 9.8% Sales Growth in FY2003
October 18, 2004
- PRESS SEMINAR
October 18, 2004
- Survey Highlights Growing Awareness of GE Drugs: Sawai
October 18, 2004
- MONITOR
October 18, 2004
- Mr Morioka Calls For Mega-mergers of Domestic Firms
October 18, 2004
- MEDICAL DEVICE NEWS IN BRIEF
October 18, 2004
- REGULATORY NEWS IN BRIEF
October 11, 2004
- BULLETIN
October 11, 2004
- Wholesalers' Gross Profit Ratio Lowest on Record: FJPWA
October 11, 2004
- Criteria Shown for Med. Institutions Operated by Stock Companies
October 11, 2004
- WORLD NEWS IN BRIEF
October 11, 2004
- Major Hospitals Required to Report Serious Medical Accidents
October 11, 2004
- Camurus Hopes to License Its Innovative DDS Technology in Japan: Dr Westrin
October 11, 2004
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 11, 2004
- IFPW General Membership Meeting
October 11, 2004
- In-house Product Launchings Expected from FY2008: Nippon Kayaku
October 11, 2004
- NHI Pricing Should Be Based on Market Price Principle: Prof. Tsutsumi
October 11, 2004
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
